Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |